Canal SEMI COVID-19 para Profesionales
Bienvenido/a al canal COVID-19 para profesionales de la Sociedad Española de Medicina Interna (SEMI).
Este espacio pretende servir de punto de encuentro entre internistas para compartir información sobre el coronavirus, así como para plantear consultas e intercambiar datos que puedan ser de utilidad al conjunto de los profesionales de la SEMI en estos momentos.
Además de poder compartir documentos, protocolos, análisis e impresiones, a través de los siguientes enlaces puedes acceder a:
-información en tiempo real de la evolución de la emergencia sanitaria declarada en España por el COVID-19 (por CC.AA.)
-documentos técnicos del Ministerio de Sanidad para profesionales sanitarios.
-últimos informes diarios sobre la pandemia en España del Instituto de Salud Carlos III (ISCIII).
Este canal nos permitirá estar coordinados e informados sobre todo lo relacionado con el coronavirus (Covid-19).
A través de estos enlaces, podrá acceder a los canales de The New England Journal of Medicine, The BMJ, The Lancet, y JAMA.
Además, puedes acceder en abierto, a la edición en español del mini-manual de Kamps&Hoffman sobre COVID-19 con información recopilada sobre epidemiología, virología, inmunología, diagnóstico y manifestación clínica de la enfermedad por SARS-CoV-2, entre otros muchos aspectos. Edición del 29 de marzo de 2020.
Para acceder a todas las funcionalidades de está página, recuerde que deberá estar identificado en la web con sus credenciales de socio de SEMI (usuario y contraseña).
ACCEDE AL FORO PARA PROFESIONALES DE SEMI
Documentos técnicos, protocolos y esquemas terapéuticos recopilados por SEMI y sus entidades miembro sobre COVID-19.
-DOCUMENTOS OFICIALES: MINISTERIOS, COMUNIDADES AUTÓNOMAS (CC.AA.) Y OTROS ORGANISMOS DE LA ADMINISTRACIÓN
Actualización de la Estrategia de Vacunación frente a COVID-19. Preguntas y respuestas frecuentes. Abril de 2021
Una visión global de la pandemia COVID-19: qué sabemos y qué estamos investigando desde el CSIC
Estudio ENE-COVID19: Infome final. Estudio Nacional de Sero-epidemiología de la infección por SARS-CoV-2 en España. 6 de julio de 2020
Estudio ENE-COVID19: Segunda ronda Estudio Nacional de Sero-epidemiología de la infección por SARS-CoV-2 en España. Informe preliminar a fecha 3 de junio de 2020
Clinical Management of COVID-19. OMS-WHO. 27 de mayo de 2020
Sospechas de reacciones adversas notificadas con tratamientos utilizados en COVID-19
Tratamientos disponibles para el manejo de la infección respiratoria por SARS-CoV-2
Información Científico-Técnica. Enfermedad por Coronavirus COVID-19. Actualización a 18 de mayo de 2020
Estudio ENE-COVID19: Primera ronda Estudio Nacional de Sero-epidemiología de la infección por SARS-CoV-2 en España. Informe Preliminar a fecha 13 de mayo de 2020
Informe sobre la situación de COVID-19 en España. 7 de mayo de 2020
Estrategia de Diagnóstico, vigilancia y control en la fase de transición de la pandemia de COVID-19. Indicadores de seguimiento. 6 de mayo de 2020
Coronavirus Disease 2019 (COVID-19). Medical Virology: from Pathogenesis to Disease Control
COVID-19. Recomendaciones sanitarias para la estrategia de transición. CCAES. Ministerio Sanidad. 25 de abril de 2020
Cloroquina/Hidroxicloroquina: precauciones y vigilancia de posibles reacciones adversas en pacientes con COVID-19.22.04.20
Interpretación de las pruebas diagnósticas frente a SARS-CoV-2. 22 de abril de 2020
Coronavirus disease 2019 (COVID-19) Situation Report – 84. OMS.
Instrucciones de la AEMPS para el uso compasivo de Tocilizumab (TCZ)
Prevención y control de la infección en el manejo de pacientes con COVID-19. Versión 14 de abril
EPICOS - Ensayo Clínico para la Prevención de la Infección por Coronavirus en Sanitarios
Guía para la utilización de test rápidos de anticuerpos para COVID-19. Ministerio de Sanidad
COVID-19. EU recommendations for testing strategies. Comisión Europea.
La AEMPS informa sobre el buen uso de medicamentos relacionados con COVID-19
Guía para la utilización de test diagnósticos para COVID-19. 6 de abril de 2020
Información Científica-Técnica. Enfermedad por Coronavirus (COVID-19). Actualización, 4 de abril de 2020
Procedimientos de actuación frente al COVID-19 en Asturias. Protocolo general. 1 de abril
Procedimiento de actuación frente a casos de infección por el nuevo Coronavirus SARS-CoV-2. Actualizado a 31 de marzo
Guía de actuación frente a COVID-19 en los profesionales sanitarios y sociosanitarios. Versión 31 de marzo
Recomendaciones de la AEMPS para la gestión de medicamentos para el manejo de pacientes en fase terminal
Recomendaciones para el manejo, prevención y control de COVID-19 en Unidades de Diálisis. Versión de 25 de marzo de 2020
Procedimiento de actuación para los servicios de prevención de riesgos laborales frente a la exposición al SARS‐CoV‐2. 30 de marzo de 2020
Informe del Comité de Bioética de España sobre los aspectos bioéticos de la priorización de recursos sanitarios en el contexto de la crisis del coronavirus
Informe sobre la incidencia del COVID-19 en España. Actualización número 57. Ministerio de Sanidad. CCAES.
Información Científico-Técnica de la enfermedad por Coronavirus COVID-19. CCAES. Ministerio de Sanidad. Actualización 26 de marzo de 2020
Tratamientos disponibles para el manejo de la infección respiratoria por SARS-CoV-2. AEMPS. 26 de marzo
Manejo clínico del COVID-19: tratamiento médico. Ministerio de Sanidad
La AEMPS informa de la distribución controlada de todo el stock de hidroxicloroquina-cloroquina
Guía de prevención y control frente al COVID-19 en residencias de mayores y otros centros de servicios sociales de carácter residencial
Actualización Nº 52. Enfermedad por el coronavirus (COVID-19). 22.03.2020
Informe Fake News y desinformaciones sobre el virus COVID-19 en fuentes abiertas
Protocolo de derivación de pacientes con COVID-19 a hoteles sanitarizados de la Comunidad de Madrid.
Manejo clínico del COVID-19: atención hospitalaria
Manejo de la mujer embarazada y el recién nacido con COVID-19
Procedimiento de atención y seguimiento domiciliario de casos posibles y confirmados por SARS-CoV-2 (COVID-19)
Toma y preparación de las muestras biológicas en domicilio en casos en investigación por SARS-CoV-2
Medicamentos antihipertensivos que actúan sobre el sistema renina angiotensina e infección por COVID-19
La AEMPS informa que ningún dato indica que el ibuprofeno agrave las infecciones por COVID-19
Guía de actuación con los profesionales sanitarios en el caso de exposiciones de riesgo a COVID-19 en el ámbito sanitario
Boletín Oficial del Estado (BOE). 15 de marzo de 2020.
-EPIDEMIOLOGÍA, TRANSMISIÓN Y PATOGÉNESIS:
Virology, transmission, and pathogenesis of SARS-CoV-2
Natural History of Asymptomatic SARS-CoV-2 Infection
COVID-19: from epidemiology to treatment
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses
Tail risk of contagious diseases
Novel viruses, old data, and basic principles: how to save lives and avoid harm amid the unknown
Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset
Epidemiology of and Risk Factors for Coronavirus Infection in Health Care Workers
BCG-induced trained immunity: can it offer protection against COVID-19?
COVID-19 and Postinfection Immunity
Changes in SARS-CoV-2 Positivity Rate in Outpatients in Seattle and Washington State, March 1-April 16, 2020
SARS-COV-2 was already spreading in France in late December 2019
A cohort of patients with COVID-19 in a major teaching hospital in Europe
The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application
Death and dying during the pandemic
Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)
This Time Must Be Different: Disparities During the COVID-19 Pandemic
COVID-19 Epidemic: Exercise or Not to Exercise; That is the Question!
Impact of contact tracing on SARS-CoV-2 transmission
Is temperature reducing the transmission of COVID-19?
Respiratory virus shedding in exhaled breath and efficacy of face masks
Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility
Asymptomatic Transmission, the Achilles’ Heel of Current Strategies to Control Covid-19
Global Virology III: Virology in the 21st Century
The convalescent sera option for containing COVID-19
Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period. Science.
Meeting the Care Needs of Older Adults Isolated at HomeDuring the COVID-19 Pandemic
Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study
Covid-19 and Immunity in Aging Populations — A New Research Agenda
Spread of SARS-CoV-2 in the Icelandic Population
COVID-19 Outbreak Associated with Air Conditioning in Restaurant, Guangzhou, China, 2020
Temporal dynamics in viral shedding and transmissibility of COVID-19
Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period
The Mental Health Consequences of COVID-19 and Physical Distancing
A Sneeze
Coronavirus Disease 2019 (COVID-19) Pandemic and Pregnancy
Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review (Review)
Guidance for discharge and ending isolation in the context of widespread community transmission of COVID-19 – first update. ECDC.
Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes
Covid-19: Why Germany’s case fatality rate seems so low
The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application
Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing
Early dynamics of transmission and control of COVID-19: a mathematical modelling study
COVID-19 Science Report: Containment Measures
First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA
Ten Weeks to Crush the Curve
Modelización Epidemiológica del Covid-19 para España
Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host−Virus Interaction, and Proposed Neurotropic Mechanisms
The outbreak of COVID-19: An overview
COVID-19: Gastrointestinal manifestations and potential fecal-oral transmission
Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States
Timely research papers about COVID-19 in China
The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?
Responding to the COVID-19 pandemic in complex humanitarian crises
Patients with respiratory symptoms are at greater risk of COVID-19 transmission
Canadian Geriatrics Society COVID-19 Recommendations for Older Adults.What Do Older Adults Need To Know?
SARS-CoV-2 Infection in Children
Mass masking in the COVID-19 epidemic: people need guidance
How will country-based mitigation measures influence the course of the COVID-19 epidemic?
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Revista Cell
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
COVID-19: Una propuesta de estadificación clínico-terapéutica. Journal of Heart and Lung Transplantation
Report sulle caratteristiche dei pazienti deceduti positivi a COVID-19 in Italia Il presente report è basato sui dati ggiornati al 13 Marzo 2020
COVID-19 and Italy: what next?
Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents
Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. TNEJM
2019 novel coronavirus patients’ clinical characteristics, discharge rate and fatality rate of meta-analysis
Coronavirus disease 2019 (covid-19): a guide for UK GPs. BMJ
Contamination of healthcare workers’ mobile phones by epidemic viruses. CMI
National UK programme of community health workers for COVID-19 response
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. MMR
Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2)
Protocolo de ventilación múltiple con un solo ventilador para situaciones de pandemia-catástrofe sanitaria
Coronavirus Disease 2019 (COVID-19) in Italy. JAMA Infographic
Comunicado de la Sociedad Española de Neurología (SEN) sobre la enfermedad por COVID-19.
-PREVENCIÓN Y VACUNACIÓN:
Recomendaciones para el diagnóstico y tratamiento de eventos trombóticos tras la vacunación frente a la COVID-19. Documento FACME actualizado a fecha 4 de junio (versión 5). Disponible, aquí
Sobre las condiciones de riesgo alto de padecer enfermedad grave por COVID-19 y las decisiones de priorización de la vacunación (FACME)
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Collaborative delirium prevention in the age of COVID-19
Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe
Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis
Routine Venous Thromboembolism Prophylaxis May Be Inadequate in the Hypercoagulable State of Severe Coronavirus Disease 2019
Coronavirus Disease 2019 (COVID-2019) Infection Among Health Care Workers and Implications for Prevention Measures in a Tertiary Hospital in Wuhan, China
Moving Personal Protective Equipment Into the Community Face Shields and Containment of COVID-19
Hypertension and COVID-19
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
II Informe OMC Comisión Asesora COVID-19 sobre uso mascarillas en ámbito sanitario y población general
ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaques
SARS-CoV-2 Rates in BCG-Vaccinated and Unvaccinated Young Adults
SARS-CoV-2 Vaccines: Status Report
The First, Comprehensive Immunological Model of COVID-19: Implications for Prevention, Diagnosis, and Public Health Measures
Clinician Education and Adoption of Preventive Measures for COVID-19: A Survey of a Convenience Sample of General Practitioners in Lombardy, Italy
Developing Covid-19 Vaccines at Pandemic Speed
Advice on the use of masks in the context of COVID-19
Vitamin D supplementation could prevent and treat influenza, coronavirus, and pneumonia infections
A cluster randomised trial of cloth masks compared with medical masks in healthcare workers
Vitamin D supplementation could prevent and treat influenza, coronavirus, and pneumonia infections
A serological assay to detect SARS-CoV-2 seroconversion in humans
COVID-19: protecting health-care workers
National UK programme of community health workers for COVID-19 response
Am I Part of the Cure or Am I Part of the Disease? Keeping Coronavirus Out When a Doctor Comes Home
Recomendaciones para Profesionales de Atención Domiciliaria en Cuidados Paliativos. SECPAL-AECPAL
Protocolo de actuación SPRL COVID-19. Salud Madrid
Cuidado emocional del personal sanitario ante el COVID-19
Aclaraciones sobre el uso de mascarillas
Personal Sanitario. Precauciones a considerar en su domicilio.
-DIAGNÓSTICO:
Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2
Waiting for Certainty on Covid-19 Antibody Tests — At What Cost?
COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?
Prognostic Value of Cardiovascular Biomarkers in COVID-19: A Review
Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis
British Thoracic Society Guidance on Respiratory Follow Up of Patients with a Clinico-Radiological Diagnosis of COVID-19 Pneumonia
Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction–Based SARS-CoV-2 Tests by Time Since Exposure
A proposed lung ultrasound and phenotypic algorithm for the care of COVID-19 patients with acute respiratory failure
Chest CT for detecting COVID-19: a systematic review and meta-analysis of diagnostic accuracy
Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals
COVID-19: False Negatives / Projections for Africa / Predictive Biomarkers
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19
Interpreting a covid-19 test result
Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection
Interpreting Diagnostic Tests for SARS-CoV-2
CPR in the Covid-19 Era — An Ethical Framework
Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19
Interpreting Diagnostic Tests for SARS-CoV-2
COVID-19 diagnosis and management: a comprehensive review
Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases
IDSA COVID-19 Antibody Testing Primer
Covid-19: a remote assessment in primary care
Global Progress on COVID-19. Serology-Based Testing
Endothelial cell infection and endotheliitis in COVID-19
False-negative results of initial RT-PCR assays for COVID-19: a systematic review.
Research Update. Comorbidity and COVID-19. NHS.
Acute Kidney Injury (AKI) and COVID-19. NHS
Prediction models for diagnosis and prognosis of Covid-19 infection: systematic review and critical appraisal
Interpretación de las pruebas diagnósticas frente a SARS-CoV-2. Ministerio de Sanidad, SEIMC e ISCIII
COVID-19 outbreak: less stethoscope, more ultrasound
Covid-19 pandemic and the skin - What should dermatologists know?
Prediction models for diagnosis and prognosis of Covid-19 infection: systematic review and critical appraisal
Covid-19: testing times
The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society
Lower mortality of COVID-19 by early recognition and intervention: experience from Jiangsu Province
Covid-19: four fifths of cases are asymptomatic, China figures indicate
A serological assay to detect SARS-CoV-2 seroconversion in humans
Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)
Positive RT-PCR Test Results in Patients Recovered From COVID-19
Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020
Point-of-Care RNA-Based Diagnostic Device for COVID-19
Performance of VivaDiagTM COVID-19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID-19 in acute patients referring to emergency room department
Diagnostic Testing for the Novel Coronavirus
Brescia-COVID Respiratory Severity Scale (BCRSS)/Algorithm
Diagnostic Utility of Clinical Laboratory Data Determinations for Patients with the Severe COVID-19
Combination of RT-qPCR Testing and Clinical Features For Diagnosis of COVID-19 facilitates management of SARS-CoV-2 Outbreak
Antibody responses to SARS-CoV-2 in COVID-19 patients: the perspective application of serological tests in clinical practice
Coronavirus in pregnancy and delivery: rapid review
Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis
Radiological Society of North America Expert Consensus Statement on Reporting Chest CT Findings Related to COVID-19. Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA
Coronavirus Disease 2019 (COVID-19) and Pregnancy: What obstetricians need to know
Manejo COVID-19. H. Ramçon y Cajal. Infecciosas
Viral load of SARS-CoV-2 in clinical samples
Recomendaciones de la Sociedad Española de Neurología (SEN) en relación con la pérdida de olfato como posible síntoma precoz de infección por CoVID-19
Laboratory testing for coronavirus disease (COVID-19) in suspected human cases. WHO-OMS
Utilidad de la ecografía pulmonar en la enfermedad COVID-19. Medicina Interna H.U.Torrecárdenas
Diagnostic Testing for the Novel Coronavirus
International Pulmonologist's Consensus on COVID-19
COVID-19 Science Report: Diagnostics. SSHSPH
COVID-19 Prioritization of Diagnostic Testing. IDSA
UC Infectious Diseases Division. Work up guidance algorrithm
Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases. Radiology
Well-aerated Lung on Admitting Chest CT to Predict Adverse Outcome in COVID-19
Plan asistencial de Medicina Interna COVID-19. HUCA. 22 de marzo
Sistemática de actuación ante pacientes con PCR negativa y sospecha de infección por COVID-19.
Recomendaciones de la SEORL-CCC para la práctica de la especialidad durante la pandemia de COVID-19. 22 de marzo.
Protocolo de manejo COVID-19. Hospital Universitario de Getafe
Guía práctica para el manejo de los pacientes ingresados con infección por SARS-CoV-2. Hospital General Universitario Gregorio Marañón
Gestación y coronavirus. Hospital Universitario Central de Asturias
Criterio de Atención Clínica y de derivación hospitalaria de pacientes diagnosticados como casos probables de infección por SARS-CoV-2
Guía básica de indicaciones de pruebas de imagen en la infección COVID-19 (V1. 21/3/2020)
Comunicado de la SEORL-CCC
-CLÍNICA, COMPLICACIONES Y PRONÓSTICO:
umoral Immune Response to SARS-CoV-2 in Iceland
Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study
Neuropathological Features of Covid-19
Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study
COVID-19: the vasculature unleashed
Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series
Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019 A Review
Cardiovascular disease and COVID-19
Viral and host factors related to the clinical outcome of COVID-19
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy
Characteristics and clinical significance of myocardial injury in patients with severe coronavirus disease 2019
Deep Vein Thrombosis in Hospitalized Patients with Coronavirus Disease 2019 (COVID-19) in Wuhan, China: Prevalence, Risk Factors, and Outcome
Acute kidney injury in patients hospitalized with COVID-19
The trinity of COVID-19: immunity, inflammation and intervention
European Society of Trauma and Emergency Surgery (ESTES) recommendations for trauma and emergency surgery preparation during times of COVID‑19 infection
Emergency trauma care during the outbreak of corona virus disease 2019 (COVID-19) in China
Emergency surgery during the COVID-19 pandemic: what you need to know for practice
COVID-19 Infection Implications for Perioperative and Critical Care Physicians
COVID-19 - ESSKA guidelines and recommendations for resuming elective surgery
Cardiac Surgery during the COVID-19 Pandemic: Perioperative Considerations and Triage Recommendations
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
A need for prone position CPR guidance for intubated and non-intubated patients during the COVID-19 pandemic
Use of Prone Positioning in Nonintubated Patients With COVID-19 and Hypoxemic Acute Respiratory Failure
Potential association between COVID-19 mortality and healthcare resource availability
Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan
Predictors of Mortality for Patients with COVID-19 Pneumonia Caused by SARS-CoV-2: A Prospective Cohort Study
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Clinical course and mortality risk of severe COVID-19
Severe Covid-19
Global guidance for surgical care during the COVID-19 pandemic
A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2
Acute kidney injury in patients hospitalized with Covid-19
Thromboembolic risk and anticoagulant therapy in COVID‐19 patients: Emerging evidence and call for action
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia
Incidence of venous thromboembolism in hospitalized patients with COVID‐19
Incidence of thrombotic complications in critically ill ICU patients with COVID-19
Venous thromboembolic events in anticoagulated COVID-19 patients
Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up
COVID-19 and its implications for thrombosis and anticoagulation
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
Acute myocardial injury is common in patients with covid-19 and impairs their prognosis
Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia
Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China
Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic
Clinical Management of Stable Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus
Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China
Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19)
Characteristic CT findings distinguishing 2019 novel coronavirus disease (COVID-19) from influenza pneumonia
Association Between Hypoxemia and Mortality in Patients With COVID-19
D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19
Thromboembolic risk and anticoagulant therapy in COVID-19 patients: Emerging evidence and call for action
Coronavirus Infections and Type 2 Diabetes—Shared Pathways with Therapeutic Implications
The duration of viral shedding of discharged patients with severe COVID-19
Management of Acute Myocardial Infarction During the COVID-19 Pandemic
SARS-CoV-2 and viral sepsis: observations and hypotheses
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study
Cardiovascular Disease, Drug Therapy,and Mortality in Covid-19
Clinical phenotypes of SARS-CoV-2: Implications for clinicians and researchers
Pulmonary Embolism in COVID-19 Patients: Awareness of an Increased Prevalence
Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID-19) infected patients
The trinity of COVID-19: immunity, inflammation and intervention
Role of immunosuppressive therapy in rheumatic diseases concurrent with Covid-19
Coronavirus Infections and Type 2 Diabetes—Shared Pathways with Therapeutic Implications
The duration of viral shedding of discharged patients with severe COVID-19
Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome
Variation in COVID-19 Hospitalizations and Deaths Across New York City Boroughs
Respiratory health in athletes: facing the COVID-19 challenge
Respiratory Muscle Performance Screening for Infectious Disease Management Following COVID-19: A Highly Pressurized Situation
SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes
COVID-19 and Older Adults: What We Know
Coronavirus, COVID-19, SARS
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
Prediction for Progression Risk in Patients with COVID-19 Pneumonia: the CALL Score
Prediction for Progression Risk in Patients with COVID-19 Pneumonia: the CALL Score
Prevalence and Impact of Myocardial Injury in Patients Hospitalized with COVID19 Infection
Clinicolaboratory study of 25 fatal cases of COVID-19 in Wuhan
Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China
Myocardial Injury in Patients Hospitalized with COVID-19
Profile of IgG and IgM antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Physician Deaths from Corona Virus Disease (COVID-19)
Neutrophil-to-Lymphocyte Ratio Predicts Severe Illness Patients with 2019 Novel Coronavirus in the Early Stage
Gastrointestinal Complications in Critically Ill Patients with COVID-19
Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational studys
Guide to Understanding the 2019 Novel Coronavirus
Covid-19: four fifths of cases are asymptomatic, China figures indicate
Inpatient Care of Patients with COVID-19: A Guide for Hospitalists
COVID-19 and diabetes mellitus: what we know, how our patients should be treated now, and what should happen next
Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections
Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019
Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures
Characteristics of Hospitalized Adults With COVID-19 in an Integrated Health Care System in California. JAMA
Cytokine Storm Syndrome
Management of COVID-19 Respiratory Distress
Factors associated with hospitalization and critical illness among 4,103 patients with Covid-19 disease in New York City
Coronavirus as silent killer: recent advancement to pathogenesis, therapeutic strategy and future perspectives
Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
Coronavirus Disease19 in Geriatrics and Long-Term Care: An Update
Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection
Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study
Symptom Screening at Illness Onset of Health Care Personnel With SARS-CoV-2 Infection in King County, Washington
Central nervous system manifestations of COVID-19: A systematic review
Guillain–Barré Syndrome Associated with SARS-CoV-2
Presenting Characteristics, Comorbidities, and Outcomes Among 5.700 Patients Hospitalized With COVID-19 in the New York City Area
Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis
ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic
COVID-19 in Hemodialysis Patients: A Report of 5 Cases
COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?
Cytokine release syndrome in severe COVID-19
Interim Guidance for Basic and Advanced Life Support in Adults, Children, and Neonates With Suspected or Confirmed COVID-19
SARS-CoV-2 and viral sepsis: observations and hypotheses
Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases
Clinical Implications of SARS-Cov2 Interaction with Renin Angiotensin System
Covid-19 Does Not Lead to a “Typical” Acute Respiratory Distress Syndrome
Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study
Symptom Screening at Illness Onset of Health Care Personnel With SARS-CoV-2 Infection in King County, Washington
Well-aerated Lung on Admitting Chest CT to Predict Adverse Outcome in COVID-19
Coronavirus: novel coronavirus (COVID-19) infection
Clinical Characteristics of Covid-19 in New York City
Coronavirus disease 2019 (COVID-19).BMJ Best Practice.
The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality
COVID-19 Clinical Trials: A Primer for the Cardiovascular and Cardio-Oncology Communities
The Clinical Presentation and Immunology of Viral Pneumonia and Implications for Management of Coronavirus Disease 2019
Smoking is Associated with COVID-19 Progression: A Meta-Analysis
Novel 2019 Coronavirus SARS-CoV-2 (COVID-19): An Overview for Emergency Clinicians
Clinical observation and management of COVID-19 patients
Tissue Plasminogen Activator (tPA) Treatment for COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS): A Case Series
Pulmonary thrombosis in 2019-nCoV pneumonia?
Incidence of thrombotic complications in critically ill ICU patients with COVID-19
Hematological findings and complications of COVID-19
Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease
Nervous system involvement after infection with COVID-19 and other coronaviruses
Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications
Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens
Immune Thrombocytopenic Purpura in a Patient with Covid-19
Neurologic Features in Severe SARS-CoV-2 Infection
Presymptomatic Transmission of SARS-CoV-2 — Singapore, January 23–March 16, 2020
Characteristics of Health Care Personnel with COVID-19 —United States, February 12–April 9, 2020
Asymptomatic and Presymptomatic SARS-CoV-2 Infections in Residents of a Long-Term Care Skilled Nursing Facility —King County, Washington, March 2020
Oncology Practice During the COVID-19 Pandemic
Awareness, Attitudes, and Actions Related to COVID-19 Among Adults With Chronic Conditions at the Onset of the U.S. Outbreak
Hypertension, the renin–angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19c
Not Dying Alone — Modern Compassionate Care in the Covid-19 Pandemic
The Variety of Cardiovascular Presentations of COVID-19
Pulmonary and Cardiac Pathology in Covid-19: The First Autopsy Series from New Orleans
Dysregulation of immune response in patients with COVID-19 in Wuhan, China
Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered 2 patient cohort and their implications
ACE2 the Janus-faced protein – from cardiovascular protection to severe acute respiratory syndrome-coronavirus and COVID-19
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations
Diagnosis and Management of COVID-19 Disease. American Thoracic Society
Pathological study of the 2019 novel coronavirus disease (COVID-19) through post-mortem core biopsies
Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19)
COVID-19 Autopsies, Oklahoma, USA
COVID-19: consider cytokine storm syndromes and immunosuppression
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 Infection
Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in geneticallypredisposed subjects?
Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2
Guidance for Cardiac Electrophysiology During the Coronavirus (COVID-19)
Renin-Angiotensin System Blockers and the COVID-19 Pandemic
Estimates of the severity of coronavirus disease 2019: a model-based analysis
Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease
Acute Acro-ischemia in the child at the time of COVID-19
Practical guidance for the prevention of thrombosis and management of coagulopathy and disseminated intravascular coagulation of patients infected
Screening and Severity of Coronavirus Disease 2019 (COVID-19) in Children in Madrid, Spain
Coronavirus Disease-2019: Implication for the care and management of patients with systemic lupus erythematosus
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
Pluristem Reports Preliminary Data from its COVID-19 Compassionate Use Program, Treating Seven Patients with Acute Respiratory Failure
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed
Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension
Obesity and its Implications for COVID-19 Mortality
Hypertension and its severity or mortality in Coronavirus Disease 2019
Effects of hypertension, diabetes and coronary heart disease on COVID-19 diseases severity: a systematic review and meta-analysis
Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China
COVID-19 and the ReninQ1 Angiotensin System
COVID 19 and the Patient with Obesity – The Editors Speak Out
Clinical considerations for patients with diabetes in times of COVID-19 epidemic
COVID-19 and the Heart
An algorithm for managing QT prolongation in Coronavirus Disease 2019 (COVID-19) patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin: Possible benefits of intravenous lidocaine
Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease Q2 Q1 19 (COVID-19). Mayo Clinic
Pandemic palliative care: beyond ventilators and saving lives
Protocolo de manejo y tratamiento de los pacientes críticos con neumonía grave por COVID-19. Hospital Vall d'Hebrón
Recent advances in the detection of respiratory virus infection in humans”
Review of “Viral dynamics in mild and severe cases of COVID-19”
Viral dynamics in mild and severe cases of COVID-19
Covid-19 in South Korea — Challenges of Subclinical Manifestations
COVID‐19: Interim Guidance on Management Pending Empirical Evidence. From an American Thoracic Society‐led International Task Force
Renin-Angiotensin System Blockers and the COVID-19 Pandemic At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy
Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China
Urgencia respiratoria en pacientes COVID-19. Hospital Universitario Infanta Cristina
Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. OMS
The effect of hydroxychloroquine on thrombosis prevention and antiphospholipid antibody levels in primary antiphospholipid syndrome: A pilot open label randomized prospective study
Proceso de Atención al Final de la Vida. Hospital General Universitario Gregorio Marañón
Association of QT-Prolonging Medications With Risk of Autopsy-Defined Causes of Sudden Death
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)
Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis
Pandemic palliative care: beyond ventilators and saving lives
Protocolo de manejo clínico de los pacientes infectados por Coronavirus CoV-2 (COVID-19). SERGAS. Área Sanitaria de Coruña y Cee.
COVID-19 and Diabetes: can DPP4 inhibition play a role?
Effects of hypertension, diabetes and coronary heart disease on COVID-19 diseases severity: a systematic review and meta-analysis
COVID-19: Knowns, Unknowns, and Questions
Enfermedades autoinmunes y COVID-19. Experiencias en el manejo de estos pacientes del Hospital Clinic de Barcelona
Liver injury during highly pathogenic human coronavirus infections
Clinical Features of COVID-19-Related Liver Damage
Liver injury in COVID-19: management and challenges
Recomendaciones ante una parada cardiaca durante la pandemia de COVID-19
Pragmatic Recommendations for Intubating Critically Ill Patients with Suspected COVID-19
Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis
Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study
Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)
Cytokines Storm Syndrome (CSS)
COVID-19 infection and rheumatoid arthritis: Faraway, so close!
COVID-19: the new challenge for rheumatologists
Management of Critically Ill Adults With COVID-19
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
Physiotherapy Management for COVID-19 in the Acute Hospital Setting: Recommendations to guide clinical practice
Functional exhaustion of antiviral lymphocytes in COVID-19 patients
Immunosuppression for hyperinflammation in COVID-19: a doubleedged sword?
Recomendaciones para el manejo de la Miastenia Gravis (MG) y el síndrome miasténico de Lambert-Eaton (LEMS) durante la pandemia de COVID-19
COVID-19 Illness in Native and Immunosuppressed States: A Clinical-Therapeutic Staging Proposal
COVID-19: consider cytokine storm syndromes and immunosuppression
Implicaciones de la pandemia por COVID-19 para el paciente con insuficiencia cardíaca, trasplante cardíaco y asistencia ventricular. Recomendaciones de la SEC
Recomendaciones para manejo de pacientes con infección por COVID-19 en el contexto de una intervención quirúrgica urgente o electiva. Asociación Española de Cirujanos (AEC)
Recomendaciones de consenso respecto al soporte respiratorio no invasivo en el paciente adulto con insuficiencia respiratoria aguda secundaria a infección por SARSCoV-2
Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study
Clinical associations of renal involvement in ANCA-associated Vasculitis
Teleconferencia 10/03/2020 UCI de Lombardia (Milan,Monza,Bergamo,Pavia,Lecco) área de máxima difusión de COVID-19 en Italia desde febrero 2020
Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. WHO
Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19)
Clinical Characteristics of Coronavirus Disease 2019 in China. TNEJOM
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State
Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths. JMII
Consideraciones sobre el abordaje invasivo de la cardiopatía isquémica y estructural durante el brote de coronavirus COVID-19. Documento de consenso de la Asociación de Cardiología Intervencionista y la Asociación de Cardiopatía Isquémica y Cuidados Agudos Cardiovasculares de la Sociedad Española de Cardiología
COVID-19 e inhibidores de la enzima convertidora de angiotensina y bloqueadores del receptor de angiotensina ¿Cuál es la evidencia? JAMA
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Article CELL
COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?
Recomendaciones del Grupo de Trabajo de VMNI de la Sociedad Española de Urgencias y Emergencias respecto al soporte respiratorio no invasivo en el paciente adulto con insuficiencia respiratoria aguda secundaria a infección por SARS-CoV-2
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
Guías de manejo en terapia intensiva
Manejo del SDRA de la Sociedad Catalana de Críticos
Síndrome de Distrés Respiratorio Agudo: Abordaje basado en evidencia
Protocolo de atención a pacientes en situación de gravedad o últimos días y éxitus en la crisis del COVID-19. Hospital Universitario La Paz de Madrid.
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Recomendaciones de consenso respecto al soporte respiratorio no invasivo en el paciente adulto con insuficiencia respiratoria aguda secundaria a infección por SARSCoV-2
-TRATAMIENTO:
Proceso Asistencial Integrado para la atención a las personas afectadas por SARS-CoV-2 (SACYL)
Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study
Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
Direct oral anticoagulant plasma levels’ striking increase in severe COVID-19 respiratory syndrome patients treated with antiviral agents: The Cremona experience
Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study
Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic Review
Hydroxychloroquine for the Prevention of Covid-19 — Searching for Evidence
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
Expression of concern: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
COVID-19, hypertension and cardiovascular diseases: Should we change the therapy?
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID-19
Anakinra for severe forms of COVID-19: a cohort study
Scientific and Standardization Committee Communication: Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID-19
Caution against corticosteroid-based COVID-19 treatment
Considerations in prophylaxis and treatment of VTE in COVID-19 Patients
COVID-19 rapid guideline: antibiotics for pneumonia in adults in hospital
Vitamin D supplementation could possibly improve clinical outcomes of patients infected with Coronavirus-2019 (COVID2019)
The role of vitamin D in the prevention of coronavirus disease 2019infection and mortality
Routine Venous Thromboembolism Prophylaxis May Be Inadequate in the Hypercoagulable State of Severe Coronavirus Disease 2019
Potential Role of Vitamin D in the Elderly to Resist COVID-19 and to Slow Progression of Parkinson’s Disease
Perspective: improving vitamin D status in the management of COVID-19
COVID-19 rapid evidence summary: angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) in people with or at risk of COVID-19
COVID-19 rapid evidence summary: Long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) for people with or at risk of COVID-19
COVID-19 and the use of angiotensin-converting enzyme inhibitors and receptor blockers
Treatment algorithm for COVID-19: a multidisciplinary point of view
A Review of SARS-CoV-2 and the Ongoing Clinical Trials
Ongoing Living Update of Potential COVID-19 Therapeutics: summary of rapid systematic reviews
Remdesivir for the Treatment of Covid-19 — Preliminary Report
Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
YNHHS Initial Treatment Algorithm for Hospitalized ADULTS with Non–Severe* COVID-19
Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State
Treatment of Community-Acquired Pneumonia During the Coronavirus Disease 2019 (COVID-19) Pandemic
Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis
Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin–angiotensin–aldosterone inhibitors
Direct oral anticoagulant plasma levels’ striking increase in severe COVID-19 respiratory syndrome patients treated with antiviral agents: The Cremona experience
Coronavirus Disease 2019 (COVID-19) Treatment Guidelines
Non-steroidal anti-inflammatory drugs, pharmacology, and COVID-19 infection
Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases
Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19
Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19)
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study
Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome
Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State
Ivermectin as a potential COVID-19 treatment from the pharmacokinetic point of view
Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19
Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
Vademecum for the treatment of people with COVID-19. Edition 2.0, 13 March 2020
Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options
Current Drugs with Potential for Treatment of COVID-19: A Literature Review
COVID-19 and its implications for thrombosis and anticoagulation
Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis
Association of Treatment Dose Anticoagulation with In-Hospital Survival Among Hospitalized Patients with COVID-19
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
A Trial of Lopinavir–Ritonavir in Covid-19
Usefulness of Ivermectin in COVID-19 Illness
Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19)
Hydroxychloroquine, Coronavirus Disease 2019, and QT Prolongation
Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit
Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up
Finding the dose for hydroxychloroquine prophylaxis for COVID-19; the desperate search for effectiveness
Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge
Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
Thromboembolic risk and anticoagulant therapy in COVID-19 patients: Emerging evidenceand call for action
Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidencebased guideline
The Risks of Prescribing Hydroxychloroquine for Treatment of COVID-19—First, Do No Harm
Current pharmacological treatments for COVID-19: what’s next?
Innovation in Response to the COVID-19 Pandemic Crisis
Does high cardiorespiratory fitness confer some protection against pro-inflammatory responses after infection by SARS-CoV-2?
Chloroquine and hydroxychloroquine in the context of COVID-19
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up
YNHHS Initial Treatment Algorithm for Hospitalized ADULTS with Non–Severe COVID-19
Recomendaciones sobre el tratamiento antitrombotico durante la pandemia COVID-19. Posicionamiento del Grupo de Trabajo de Trombosis Cardiovascular de la Sociedad Española de Cardiología
Management of COVID-19 Respiratory Distress
Current Status of Cell-Based Therapies for Respiratory Virus Infections: Applicability to COVID-19
Mesenchymal Stem Cell Therapy for COVID-19: Present or Future
Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection. A Randomized Clinical Trial
NIH issues treatment guidelines for COVID-19
COVID-19. Survival Guide - 1st Edition. McMaster University, Department of Medicine Hamilton, ON, Canada
Rationale for Prolonged Corticosteroid Treatment in the Acute Respiratory Distress Syndrome Caused by Coronavirus Disease 2019
Hydroxychloroquine in patients with COVID-19: an open-label, randomized, controlled trial
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up
Recomendaciones de tromboprofilaxis y tratamiento antitrombótico en pacientes con COVID-19. SETH
Deployment of convalescent plasma for the prevention and treatment of COVID-19
Considerations for Drug Interactions on QTc in Exploratory COVID-19 (Coronavirus Disease 2019) Treatment
Research Update Therapies COVID19. University Hospitals Birmingham. NHS Foundation Trust
Assessment of Evidence for COVID-19-Related Treatments: Updated 4/17/2020
Tromboprofilaxis en infección por COVID-19. SERGAS
Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics
Will Complement Inhibition be the New Target in Treating COVID-19
Mount Sinai COVID-19 Anticoagulation Algorithm
SARS-CoV-2 and COVID-19. Treatment: Lopinavir-Ritonavir. University of Washington.
SARS-CoV-2 and COVID-19. Treatment: Remdesivir. University of Washington.
Summary on compassionate use Remdesivir Gilead. EMA.
Remdesivir and SARS-CoV-2: structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites
Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency
Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir
Remdesivir, la esperanza antiviral frente al SARS-CoV-2. Revista Española de Quimioterapia
Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence
Current knowledge about the antivirals remdesivir (GS-5734) and GS441524 as therapeutic options for coronaviruses
Compounds with therapeutic potential against novel respiratory 2019 coronavirus
Remdesivir como potencial terapia frente al COVID-19. Servicio Navarro de Salud
Compassionate Use of Remdesivir for Patients with Severe Covid-19
COVID-19 Drug Therapy
Nutrition Therapy in the Patient with COVID-19 Disease Requiring ICU Care
Nutrition and Hydration: Key Weapons in the Fight Against COVID-19
Rationale for Prolonged Corticosteroid Treatment in the Acute Respiratory Distress Syndrome Caused by Coronavirus Disease 2019
Interactions with experimental COVID-19 therapies
No evidence of clinical efficacy of hydroxychloroquine in patients hospitalised for COVID-19 infection and requiring oxygen: results of a study using routinely collected data to emulate a target trial
Drug Evaluation during the Covid-19 Pandemic
Potential antiviral mechanism of hydroxychloroquine in COVID-19 and further extrapolation to celecoxib (CelebrexÒ) for future clinical trials.
The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro
Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
Protocolo de tromboprofilaxis en pacientes con infección COVID-19 del Hospital Universitario La Paz de Madrid
Clinical Outcomes of Hydroxychloroquine in Hospitalized Patients with COVID-19: A Quasi-Randomized Comparative Study
Clinical trials on drug repositioning for COVID-19 treatment
Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence
Compassionate Use of Remdesivir for Patients with Severe Covid-19
Urgent Safety Notice Use of SGLT2 inhibitors during the Covid-19 Crisis 03.04.2020
ISTH interim guidance on recognition and management of coagulopathy in COVID-19
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
Coronavirus (COVID-19) Infection in Pregnancy
Interim Guidance for Basic and Advanced Life Support in Adults, Children, and Neonates With Suspected or Confirmed COVID-19
“Less is More” in mechanical ventilation
COVID-19 pneumonia: different respiratory treatment for different phenotypes?
Assessment of Evidence for COVID-19-Related Treatments: Updated 4/8/2020
Interactions with experimental COVID-19 therapies. Liverpool University
Should chloroquine and hydroxychloroquine be used to treat COVID-19? A rapid review
Chloroquine and hydroxychloroquine in Covid-19
Information for Clinicians on Therapeutic Options for Patients with COVID-19
Antihypertensive drugs and risk of COVID-19?
Effective Treatment of Severe COVID-19 Patients with Tocilizumab
Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients
Drug Induced QTc Prolongation. COVID-19
The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro
A brief review of antiviral drugs evaluated in registered clinical trials for COVID-19
Systematic Review of the Registered Clinical Trials of Coronavirus Disease 2019 (COVID-19)
Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how
Barrier Enclosure during Endotracheal Intubation
Programa de manejo ambulatorio de pacientes con neumonía COVID-19 leve y bajo riesgo de complicaciones. Hospital Universitario Infanta Cristina
Consensus guidelines for managing the airway in patients with COVID-19
Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know
Covid-19: what treatments are being investigated?
Covid-19: FDA approves use of convalescent plasma to treat critically ill patients
Manejo de pacientes con COVID19. Hospital Universitario de Getafe
Tratamiento Antiviral e Inmunomodulador de la Infección por SARS-CoV-2. Protocolo HUyP La Fe (Valencia). 2 de marzo de 2020.
On the use of corticosteroids for 2019-nCoV pneumonia
Covid-19 y personas con enfermedades neuromusculares: Posicionamiento y recomendaciones de la Sociedad Mundial en Enfermedades Musculares (World Muscle Society)
Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand
Interactions with experimental COVID-19 therapies. University of Liverpool
Interactions with experimental COVID-19 therapies
Evaluating the drug-drug interaction risk of experimental COVID-19 therapies
Antimaláricos para el tratamiento de COVID-19
YNHHS Treatment Algorithm for Hospitalized Patient with Non–Severe COVID-19
Considerations for Pharmacologic Treatments of Patients with Confirmed COVID-19 testing for the PICU and general inpatient unit (GIU)
Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial
Convalescent Plasma to Treat COVID-19 Possibilities and Challenges
Plan de trabajo "Guía rápida del Protocolo COVID Hospital IFEMA. Marzo de 2020
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
Guía de tratamiento de adultos con enfermedad por Coronavirus (SARS-CoV-2). Hospital Universitario 12 de Octubre. Versión 9.0 (27 de Marzo de 2020)
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: an observational study
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an openlabel non-randomized clinical trial
Urgent Guidance for Navigating and Circumventing the QTc Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for COVID-19
Treating COVID-19—Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics
Renin-Angiotensin System Blockers and the COVID-19 Pandemic At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
Revisión del uso de terapias biológicas en el Síndrome de Distress Respiratorio Agudo secundario a la infección por COVID-19 (SARS-CoV-2)
Recomendaciones de fisioterapia respiratoria y ejercicio físico para personas afectadas por el COVID-19. CPFCM
Declaración HFSA/ACC/AHA aborda las preocupaciones sobre el uso de antagonistas RAAS en COVID-19
A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19
Interferon Alfacon-1 Plus Corticosteroids in Severe Acute Respiratory SyndromeA Preliminary Study
Effective Treatment of Severe COVID-19 Patients with Tocilizumab
Ventilación Mecánica No Invasiva en COVID-19. Hospital del Henares
Tratamiento de la infección por Coronavirus CoV-2 (COVID-19). Hospital Ramón y Cajal
Fármacos estudiados para combatir el SARS-CoV-2
MGH Treatment Guide for Critically Ill Patients witth COVID-19
Manejo al alta del paciente COVID-19. H.R.U. de Málaga
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an openlabel non-randomized clinical trial
EUSEM Position paper on Emergency Medical Systems response to COVID-19
Guía de Tratamiento COVID-19 Hospital 12 de Octubre
Fair Allocation of Scarce Medical Resources in the Time of Covid-19. The New England Journal of Medicine
The Toughest Triage — Allocating Ventilators in a Pandemic. The New England Journal of Medicine
Massachusetts General Hospital COVID-19 Treatment Guidance
Assessment of Evidence for COVID-19-Related Treatments. ASHP
Effective Treatment of Severe COVID-19 Patients with Tocilizumab
Manejo farmacológico de trastornos psicóticos en personas mayores con tratamiento de la infección por COVID19: interacciones y recomendaciones terapéuticas
Esquema Terapéutico Simplificado_ manejo hospitalario de pacientes con infección confirmada por SARS-CoV-2 en Medicina Interna del HUCA. 22 de marzo de 2020
Tratamiento adultos COVID-19. Hospital Universitario Guadalajara
Protocolo tratamiento COVID del Mount Sinaí
Guía de tratamiento COVID-19 del Hospital Universitario 12 de Octubre
Estudio sobre el tratamiento con hidroxicloroquina y añadiendo a ésta azitromicina
Esquema de manejo del paciente COVID-19. Hospital Universitario de Fuenlabrada.
Covid-19 — The Search for Effective Therapy. The New England Journal of Medicine
Interactions with Experimental COVID-19 Therapies
Tratamiento del COVID-19. Osakidetza
Tratamiento de la infección por Coronavirus (COVID-19) CoV-2. Hospital Universitario Ramón y Cajal. Versión 2.0 día 13 de marzo de 2020
Plan de contingencia para los servicios de Medicina Intensiva frente a la pandemia del COVID-19. SEMICYUC-SEMI
-OTROS:
Repurposed Antiviral Drugs for Covid-19—Interim WHO Solidarity Trial Results
Putting the Public Back in Public Health — Surveying Symptoms of Covid-19
Coronavirus disease 2019 (COVID-19): A literature review
New Criteria for Lupus
Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study
On the brighter side of COVID-19 induced Lockdown: Devising the collateral methods to provide Ayurveda consultation during impasse
COVID-19 and Racial/Ethnic Disparities
Violence against women during covid-19 pandemic restrictions
Occurrence, prevention, and management of the psychological effects of emerging virus outbreaks on healthcare workers: rapid review and meta-analysis
The Early Natural History of SARS-CoV-2 Infection: Clinical Observations From an Urban, Ambulatory COVID-19 Clinic
Gender Differences in Patients With COVID-19: Focus on Severity and Mortality
Covid-19 — A Reminder to Reason
Coronavirus: The Hammer and the Dance
A real-time dashboardof clinical trials for COVID-19
Innovation and Transformation in the Response to Covid-19: Seven Areas Where Clinicians Need to Lead
COVID-19: The Worst Days of Our Careers
Disease Control, Civil Liberties, and Mass Testing — Calibrating Restrictions during the Covid-19 Pandemic
What I learnt from studying doctors’ mental health over 20 years—an essay by Jenny Firth-Cozens
Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2
Covid-19 and Health Care’s Digital Revolution
Global coalition to accelerate COVID-19 clinical research in resource-limited settings
Understanding and Addressing Sources of Anxiety Among Health Care Professionals During the COVID-19 Pandemic
The Toughest Triage — Allocating Ventilators in a Pandemic
Consideraciones SEIMC para dar de alta a personal sanitario con COVID-19
Fair Allocation of Scarce Medical Resources in the Time of Covid-19
Certificaciones de Defunción de fallecidos por causas naturales, y en especial en los casos con Covid-19 o sospecha de infección por Covid-19. OMC.
The economics of a pandemic: the case of Covid-19
COVID-19: fighting panic with information
Coronavirus: the spread of misinformation
The psychological impact of quarantine and how to reduce it: rapid review of the evidence
Parenting in a time of COVID-19
The art of medicine COVID-19: the medium is the message
Virtually Perfect? Telemedicine for Covid-19
Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand
Protocolo para la comunicación telefónica de malas noticias a familiares con Coronavirus en situación de últimos días. Equipo de Soporte de Cuidados Paliativos del H.U. 12 de Octubre
Comunicado de SEMI, semFYC, SEMICYUC y SEPAR sobre MIR ante pandemia COVID-19
Si desea añadir nuevos documentos a este repositorio, por favor, contacte con oscar.veloso@fesemi.org
enviando el archivo en PDF o enlace, así como su nombre/título. Gracias.
